Home » Newsletters » BioWorld Science

BioWorld Science

June 28, 2016

View Archived Issues

Bayer initiates phase I trial of BAY-1436032 in patients with IDH1-R132X mutant solid tumors

Janssen initiates first-in-human study of JNJ-61186372 in advanced NSCLC

Hikma acquires a portfolio of six injectable products in Europe

Xencor and Novartis establish bispecific collaboration

FDA places clinical hold on Regulus' IND for RG-101 for chronic HCV infection

University of Michigan conducts first-in-human studies for new PET tracers

Puma submits MAA to the EMA for neratinib

The Jackson Laboratory patents DNA repair inhibitors

EMA recommends approval of Keytruda for advanced NSCLC

Shanghai Sun-Sail Pharmaceutical Science & Technology describes antituberculosis compounds

GW Pharmaceuticals announces positive phase III pivotal trial results for Epidiolex

LabCorp announces launch of Roche cobas EGFR Mutation Test v2

Agilis Biotherapeutics receives CRADA

RhoU GTPase shows promise as a therapeutic target for MM

Bristol-Myers Squibb receives new breakthrough therapy designation for Opdivo

First-in-human results for ONO-4232

FDA grants priority review to Ocrevus BLA for relapsing and primary progressive forms of MS

Carbavance meets primary endpoints in phase III TANGO 1 study in patients with cUTI

IL-22 linked to aberrant bone formation in spondyloarthropathies

European Commission approves Zavicefta for serious bacterial infections

PolypDx urine-based diagnostic test for adenomatous polyps launched in U.S.

Spero Therapeutics presents new MvfR inhibitor for P. aeruginosa infections

FDA accepts Advanced Accelerator Applications' NDA for Lutathera

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...